Clinical TrialID 1105

Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis

NCT04686474

Keratotic Nodular Size

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
1105
Evidence Id
1105
Core Evidence Id
1105
Source Clinical Trial Id
1088
Herb2 Clinical Trial Id
HBCT001088
Nct Id
NCT04686474
Title
Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis
Status
Phase
Study Result
No
Study Condition
Keratotic Nodular Size
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: Azadirachta indica leaves extract containing ointment intervention.
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
35
Outcome Measure
Keratotic nodular size, Lesion size will be measured by slide calipers, 12 weeks
Sponsor Collaborator
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Funded By
OTHER
Location
Muradnagar Upazilla, Comilla, Bangladesh
Other Id
BSMMU/2020/1643
Start Date
2019-10-20
Primary Completion Date
2021-01-20
Completion Date
2021-02-20
First Posted
2020-12-28
Results First Posted
Last Update Posted
2021-01-08
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04686474
Title Cn
Title En
Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis
Bilingual Status
semi_complete